Metrics to compare | GENX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGENXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.0x | −3.0x | 11.6x | |
PEG Ratio | 0.01 | 0.04 | 0.03 | |
Price/Book | −0.6x | 1.2x | 1.5x | |
Price / LTM Sales | - | 1.9x | 0.9x | |
Upside (Analyst Target) | - | 372.2% | 23.4% | |
Fair Value Upside | Unlock | 11.7% | 13.8% | Unlock |
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.